|
Nephrology
Whole blood versus serum ionized calcium concentrations in dialysis patients
Seok Hui Kang, Kyu Hyang Cho, Jong Won Park, Kyung Woo Yoon, Jun Young Do
Korean J Intern Med. 2014;29(2):226-230. Published online February 27, 2014
Background/Aims: The aim of this study is to measure the difference of ionized calcium between heparinized whole blood and serum.
Methods: We recruited 107 maintenance hemodialysis (HD) patients from our hospital HD unit. The clinical and laboratory data included ionized calcium in serum and in wh..
|
|
|
Biopsy-Proven Type 1 Renal Tubular Acidosis in a Patient with Metabolic Acidosis
Seok Hui Kang, Jin Kim, Jong Won Park
Korean J Intern Med. 2012;27(1):119-119. Published online February 28, 2012
|
|
|
Acute Kidney Injury due to Sodium Bromate Intoxication: A Report of Two Cases
Dong Hwan Ryu, Kyung Ae Jang, Seok Min Kim, Jong Won Park, Jun Young Do, Kyung Woo Yoon
Korean J Intern Med. 2011;26(4):463-465. Published online November 28, 2011
Sodium bromate is a strong oxidant used as a neutralizing solution in hair permanents, as well as an auxiliary agent in printing and dyeing. Accidental or deliberate ingestion of bromate solution has rarely been reported in Korea. The clinical manifestations of bromate intoxication are vomiting, ..
|
|
|
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients with Coronary Artery Disease and Diabetic Nephropathy: A Single Center Experience
Ki Sun Bae, Hyeong Cheon Park, Byung Seung Kang, Jong Won Park, Nu Ri Chon, Kyung Jin Oh, Young Won Yoon, You Sun Hong, Sung Kyu Ha
Korean J Intern Med. 2007;22(3):139-146. Published online September 30, 2007
BackgroundPatients with diabetic nephropathy (DN) and coronary artery disease (CAD) represent a subset of patients with high cardiovascular morbidity and mortality. The optimal revascularization strategy using either percutaneous coronary intervention (PCI) or coronary artery ..
|
|
|
Capecitabine and Oxaliplatin (XELOX) for the Treatment of Patients with Metastatic Gastric Cancer and Severe Liver Dysfunction
Seung Jae Hwang, Jong Won Park, Sehe Dong Lee, Gyong Jung Kim, Cheol Ho Sin, Seung-Hyun Nam, Bong-Seog Kim
Korean J Intern Med. 2006;21(4):252-255. Published online December 31, 2006
Gastric cancer patients with severe liver dysfunction secondary to hepatic metastases have limited treatment options. Most cytotoxic drugs have a narrow therapeutic index. Although both capecitabine and oxaliplatin have been well tolerated as single agents for patients with severe hepatic dysfunc..
|
|
|
